Energesis Pharmaceuticals is a biopharmaceutical company based in Boston, MA, dedicated to the discovery and development of drugs targeting obesity, diabetes, and related metabolic diseases. Their innovative approach focuses on increasing the body's energy expenditure, aiming to address the root causes of weight maintenance.
With a strong emphasis on leveraging recent scientific insights in brown adipose tissue biology, Energesis Pharmaceuticals aims to develop therapeutics that enhance the body's ability to burn stored fat and reduce insulin resistance. Their groundbreaking technology enables the development of drugs that increase energy expenditure, offering a promising strategy for combating both obesity and diabetes.
Generated from the website